Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 2,264

Document Document Title
JP2015168660A
To produce arylhydroquinones and arylquinones in mild conditions without using a rare metal catalyst.A method for producing arylhydroquinones by Michael addition of a an aryl compound with quinones in the presence of a catalyst. As the c...  
JP2015527322A
The Reign similar object in which an anti-fecundity operation is shown especially to a cancer cell is written in this specification. According to some embodiments, a compound contains flatness or a superficial ring system. Such a ring op...  
JP5775459B2  
JP5748660B2  
JP5725299B2  
JPWO2013121873A1
本発明のビアリール化合物の製造方法は、テ トラブチルアンモニウムヨージド、及びte rt−ブチルヒドロペルオキシド又は過酸化 水素の存在下、フェノール又はナフトー...  
JP2015086221A
To provide a novel perfluoroalkylation reaction of an aromatic compound having a perfluoroalkyl group or a fluorophenyl group, which exhibits a high yield and is convenient, and which can be applicable to a wide range of compounds.In a p...  
JP2015078224A
To provide a compound useful for therapy or suppression of diseases due to mitochondrial diseases and for adjustment of an energy biomarker in a subject.A method of treating a mitochondrial disease, adjusting 1 or more energy biomarkers,...  
JP2015078130A
To provide a polymerization inhibitor high in polymerization inhibition performance during distillation purification and small in the amount of entrainment at low vapor pressure in manufacturing carboxylic acid halide having a polymeriza...  
JP2015010050A
To provide a production method for producing a valuable product using lignin in which an effective utilization method development thereof is required without using expensive, or special facilities, agents, and processes.Hydrogen peroxide...  
JP5649454B2  
JP5641582B2  
JP2014530190A
The method of oxidizing a アルキル content molecule effectively and efficiently is provided using oxygen containing gas. At least benzimidazolyl 含有配 uses for iridium as a catalyst the iridium metal catalyst complex whose nitrog...  
JP2014189486A
To provide an oxidizer for efficient production of 1,4-benzoquinone compounds which are quite useful as synthetic intermediates for medicines and agrochemicals.1,4-Benzoquinone compounds of formula (A) are produced from corresponding alk...  
JP2014189487A
To provide a method for efficiently producing a 1,4-benzoquinone compound which is extremely useful as a synthetic intermediate of a medicine or an agrochemical or the like.There is produced corresponding 1,4-benzoquinones by oxidation w...  
JP5597924B2  
JP2014169334A
To provide effective methods of treating mitochondrial damage, such as: Friedreich's ataxia; Leber's hereditary optic neuropath; myopathy, encephalopathy, lactic acidosis and stroke-like episode (MELAS); and Kearns-Sayre syndrome.The pre...  
JP2014522378A
Naphth quinone, aza-naphth quinone and ベンズキサントン as antimalarial drugs or an anti-schistosomiasis medicine, the process of those composition, and its use.  
JP2014520894A  
JP5575350B2  
JP5567499B2  
JP5524043B2  
JP2014080578A
To provide a coloring composition that exhibits a high color value and excellent heat and light resistance; and a photosensitive coloring composition.A coloring composition contains: a phthalocyanine compound (A) represented by the speci...  
JP2014510698A
On these specifications, a new manufacturing method of アトバコン is indicated and the method includes a reaction of 1H*2* benzopyran *1 and 4 (3H) * dione and 4* (4* chlorophenyl) cyclohexane carboaldehyde. The present invention in...  
JP5479175B2  
JP2014058569A
To provide a (hetero)aryl-p-quinone derivative for a treatment of mitochondrial diseases.Methods of treating or inhibiting mitochondrial diseases, for example friedreich ataxia (FRDA), Leber's hereditary optic neuropathy (LHON), mitochon...  
JP2014051432A
To provide an anthraquinone composition having stability to reduction, oxidation and hydrolysis in producing hydrogen peroxide by an anthraquinone method, high solubility to an organic solvent, and further preferably used as a medium sup...  
JP5442977B2  
JP5441668B2  
JP5424613B2  
JP5417708B2  
JP5374162B2
Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KS...  
JP5362759B2
A mixture contains a matrix material containing specified units; and a material which is capable of emission and which contains an element of atomic number above 20. A mixture contains (a) a matrix material containing units of formula C:...  
JP5364372B2
A process for the preparation of ubihydroquinones and ubiquinones by condensation of a prenol or isoprenol with a hydroquinone or derivative thereof in the presence of 0.005-1.0 mol % of a catalyst which is a Broensted-acid, a Lewis-acid...  
JP5339040B2
To provide a novel anticancer drug that has an activity of inhibiting cell growth, and moreover, is effective even to a cancer cell having acquired resistance, and a novel compound suitable therefor. The novel naphthoquinone compound is ...  
JP5339041B2
To provide a novel anticancer drug that has an activity of inhibiting cell growth, and moreover, is effective even to a cancer cell having acquired resistance, and a novel compound suitable therefor. The novel naphthoquinone compound is ...  
JP5334169B2
To provide a method for efficiently chemically synthesizing a polyacene compound in a short time without using any organic solvent and acid/base catalyst(s) and without imposing any environmental burden. The method for chemically synthes...  
JP5318347B2
A mixture contains a matrix material containing specified units; and a material which is capable of emission and which contains an element of atomic number above 20. A mixture contains (a) a matrix material containing units of formula C:...  
JP5306653B2
A process for preparing rhein and diacerein from aloin by oxidizing aloin dissolved in a polyhydric alcohol by treatment with oxygen in the presence of an acid to obtain aloe-emodin, oxidizing aloe-emodin by treatment with a chromium-fre...  
JP2013194045A
To find a new compound having a DNA polymerase inhibitory activity, and to provide a new pharmaceutical composition utilizing the same compound.A new compound having a DNA polymerase inhibitory activity is separated from a mold parasitic...  
JP2013170168A
To provide a compound for inhibiting mammalian tumor cell proliferation.A compound for inhibiting mammalian tumor cell proliferation is a compound (I) having a structure shown in a chemical formula, wherein n is an integer from 0 to 9. T...  
JP2013533219A
This indication is related to the catalyst of the carbon catalyst of catalyst activity, for example, oxidization graphene suitable for using it for various chemical changes, and oxidization black lead. In one embodiment, it is sufficient...  
JP2013155194A
To provide compositions and methods useful for treatment or suppression of diseases due to mitochondrial disorders, such as Friedreich's ataxia, Leber's Hereditary Optic Neuropathy, Kearns-Sayre Syndrome, and mitochondrial myopathy, ence...  
JP2013522217A
The chemicals stoichiometry (mol/mol) of a metal salt oxidizer / alpha* tocopherol is [in / including the present invention relating to the method of compounding the compound of formula I, and the method oxidizing alpha* tocopherol by a ...  
JP2013515712A
The compound [according to the present invention] of formula (I) for the use in the medical treatment of osteoporosis and/or osteopenia (inside of a formula, R)1R2R3And the solvent 和物, the salt, or the prodrug which n has the meaning...  
JP5192541B2  
JP5190865B2  
JP2013507380A
This indication provides the compound and method of using the アポゴシポロン derivative for dealing with a disease and an obstacle. Especially this indication is a compound of formula I; [Formula 1]Or the method for dealing with c...  
JP5147157B2  
JP5144167B2  

Matches 301 - 350 out of 2,264